Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03316495Not ApplicableCompleted

IMPACT OF PAMPHLET ON THE KNOWLEDGE OF HEALTH EFFECT OF SMOKING

Role: lead

NCT03316755Not ApplicableCompleted

Risk Perception of Periodontal Disease

Role: lead

NCT02911272Not ApplicableCompleted

Best Partograph Action Line to Prevent Prolonged Labour

Role: lead

NCT02482116Unknown

A Comparison of Diagnostic Approaches for Malaria and Pneumonia

Role: collaborator

NCT01017068Phase 1Unknown

Aqueous Mushroom Extract and Intraocular Pressure

Role: lead

All 5 trials loaded